We want wide, fast, and affordable access for our new antiviral. It might sound counterintuitive, but a patent will help us ...
Researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, ...
As scientists, we often think we understand a virus—its structure, its tricks, the way it moves through the body. But every ...
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses ...
AZoLifeSciences on MSN6d
New AI Model Helps Predict Future Mutations in SARS-CoV-2 Spike ProteinIt's been five years since COVID-19 was declared a global pandemic. As SARS-CoV-2 shifts to endemic status, questions about ...
It's been five years since COVID-19 was declared a global pandemic. As SARS-CoV-2 shifts to endemic status, questions about ...
In this interview Prof. Dr. Kristina Kusche-Vihrog speaks about the nanomechanics of living cells and their implications for ...
This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.
Viruses like SARS-CoV-2 use sugar molecules to hide from the immune system, but scientists at Scripps Research have designed ...
CoV-2, a new merbecovirus found in bats across China, that utilises the ACE2 receptor for cellular entry—raising concerns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback